Alivus Life Sciences Quarterly Results for Trading Insights
ALIVUS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹486 Cr
QMarch 2025
Alivus Life Sciences Quarterly Results Key Highlights
- Revenue of ₹2,421 Cr in March 2025 (+0.0% vs March 2025, +5.5% vs March 2024)
- Net Profit of ₹486 Cr in March 2025 (+0.0% vs March 2025, +3.2% vs March 2024)
- EBITDA of ₹717 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 29.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹39.63 in March 2025 (+0.0% vs March 2025)
Alivus Life Sciences Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 2,560 | 2,421 | 2,295 | 2,190 | 2,138 | 5.7% | - |
| Net Profit (₹ Cr) | 544 | 486 | 471 | 467 | 419 | - | - |
| EBITDA (₹ Cr) | 803 | 717 | 686 | 671 | 631 | - | - |
| EPS (₹) | 44.30 | 39.63 | 38.43 | 38.11 | 35.63 | - | - |
| Operating Margin (%) | 30.0% | 29.0% | 30.0% | 30.0% | 29.0% | - | - |
Alivus Life Sciences Share Price Trend Around Quarterly Results
Visualize Alivus Life Sciences's 1-year price movement across quarterly results — ideal for logging trades in Alivus Life Sciences share price
chart using Tickjournal. All values in ₹.
Related Pages for Alivus Life Sciences
Additional stock information and data for ALIVUS
Revenue Trend (₹ Cr)
March 2023
2,190
March 2024
2,295
March 2025
2,421
2026
2,560
Net Profit Trend (₹ Cr)
March 2023
467
March 2024
471
March 2025
486
2026
544
Operating Margin Trend (%)
March 2023
30.0%
March 2024
30.0%
March 2025
29.0%
2026
30.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Alivus Life Sciences quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹409,758.43 Cr | 1711.1 | 14,875 | 3,125 | +10.8% | - | 21.0% | 131.6 |
|
Divis Laboratories
Sept 2025 |
₹163,940.12 Cr | 6386.5 | 2,860 | 689 | +7.1% | - | 24.1% | 245.9 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹138,072.20 Cr | 4056.7 | 3,219 | 591 | +11.3% | - | 18.4% | 231.3 |
|
Cipla
Sept 2025 |
₹109,041.12 Cr | 1349.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1270.3 | 9,135 | 1,337 | +1.1% | - | 14.6% | 78.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores